Essential Tremor in Children and Adolescent

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Terminated
CT.gov ID
NCT03487705
Collaborator
(none)
18
1
1
36
0.5

Study Details

Study Description

Brief Summary

Essential tremor (TE) is the most common abnormal movement of the adult. His diagnosis is based on a bundle of clinical arguments (Movement Disorders Society, 1998). Well characterized in the adult, little data is available concerning child. The objective of this work is (1) to define the demographic and clinical characteristics of the TE of children and adolescents, (2) to determine the electrophysiological characteristics in the child, (3) evaluate the functional impact of TE, and assess the functional impact of TE, and assess the current management modalities of TE in children and adolescent.

Condition or Disease Intervention/Treatment Phase
  • Other: electromyographic essential tremor
N/A

Detailed Description

A multicenter, descriptive cross-sectional study will include children and adolescents whose diagnosis of TE has been retained by an abnormal movement specialist before the age of 18 years.

Each child will benefit from an examination and a neurological and general clinical examination, a functional questionnaire, an electromyogram with accelerometer.

Will be determined: demographic characteristics (age, sex and ethnicity), family history of essential tremor, age of onset of tremor, tremor characteristics (location, occurrence conditions, aggravating or precipitating factors, scalability); additional examinations carried out and the treatments proposed or taken by the child as well as the functional repercussions of TE in the child.

Patients with tremor who meet the inclusion and exclusion criteria will be selected retrospectively or prospectively from the active queue of patients at each center.

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Clinical and Electrophysiological Characterization of Essential Tremor in Children and Adolescents
Actual Study Start Date :
Jul 1, 2018
Actual Primary Completion Date :
Jul 2, 2021
Actual Study Completion Date :
Jul 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: child essential tremor

electromyogram with accelerometer

Other: electromyographic essential tremor
Making a recording electromyographic recording of the essential tremors in each child included at prospective. Collect an electromyographic recording of essential tremors already made in each child included at retrospective.

Outcome Measures

Primary Outcome Measures

  1. characteristics of TE [1 day]

    échelle Fahn-Marin- Tolosa FMT

Secondary Outcome Measures

  1. determine the electrophysiological characteristics impact of TE functional questionnaire, an electromyogram with accelerometer. [1 day]

    electromyogram with accelerometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject whose age is between 3 and 18 years

  • Subject affiliated to a social security scheme

  • Parents or subjects who have been informed of the course and consequences of the study by an investigator and who have signed the informed consent form for prospective inclusion or who have given their non-opposition for retrospective inclusion.

  • Diagnosis of essential tremor established according to the diagnostic criteria of the Movement Disorders Society (1998), by a neuropediatrician or a neurologist, specialist in abnormal movements. The diagnosis is based on the presence of the following criteria: bilateral action tremor of the hands and forearms, absence of other neurological signs.

  • Availability of an electromyogram for retrospective inclusions.

Exclusion Criteria:
  • Abnormal neurological examination outside tremor

  • Family history or personal dysthyroidism

  • Existence of a global psychomotor or motor developmental delay

  • Taking medication that may induce tremor

  • known poisoning by heavy metals, bismuth, mercury, methyl bromide

  • Severe appearance of the tremor

  • Tremor suggestive of a psychogenic origin

  • Abnormal or non-existent brain MRI if family case

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Gui de Chauliac Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: Agathe ROUBERTIE, Pr, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT03487705
Other Study ID Numbers:
  • UF9770
First Posted:
Apr 4, 2018
Last Update Posted:
Nov 18, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2021